Literature DB >> 18492077

Histomorphometric assessment of bone formation in sinus augmentation utilizing a combination of autogenous and hydroxyapatite/biphasic tricalcium phosphate graft materials: at 6 and 9 months in humans.

Zvi Artzi1, Miron Weinreb, Guy Carmeli, Rony Lev-Dor, Michel Dard, Carlos E Nemcovsky.   

Abstract

OBJECTIVE: The aim of this study was to examine the efficacy of a new biphasic hydroxyapatite/tricalcium phosphate (HA/TCP) bone substitute in combination with particulate autogenous bone in sinus floor augmentation procedures.
MATERIAL AND METHODS: A simultaneous or a two-stage sinus augmentation and implant placement were conducted in 28 patients. A mixture of HA/TCP and autogenous bone chips in a 1 : 1 ratio was used as the grafting biomaterial. Cylindrical specimen bone retrieval was performed in all patients except one. Specimens were harvested either at 6 (n=14) or 9 (n=13) months post-augmentation. For histologic and histomorphometric evaluations, the non-decalcified tissue processing (Donath's technique) was performed.
RESULTS: Newly formed bone around the grafted particles was found in all samples. The encircling, highly cellular bone followed the outline of the grafted particles in direct contact. Both woven and lamellar types of bone were observed. Morphometrically, the total mean bone area fraction of all sections was 34.8+/-10.3%, increasing from 28.6+/-7.8% at 6 months to 41.6+/-8.3% at 9 months (P<0.001). Mean particle area fraction average was 25.5+/-11.6% and 23.5+/-9.3% at 6 and 9 months, respectively, with a total mean of 24.5+/-10.4%. The increase in bone area fraction was not significantly correlated to the decrease of the grafted particles area fraction.
CONCLUSIONS: The biphasic HA/TCP showed biocompatible and osteoconductive properties. This alloplast as a composite with autogenous bone chips promotes newly formed bone, which increases in its fraction along an extended healing period.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18492077     DOI: 10.1111/j.1600-0501.2008.01539.x

Source DB:  PubMed          Journal:  Clin Oral Implants Res        ISSN: 0905-7161            Impact factor:   5.977


  6 in total

1.  The influence of bone substitute materials on the bone volume after maxillary sinus augmentation: a microcomputerized tomography study.

Authors:  Sebastian Kühl; Christoph Brochhausen; Hermann Götz; Andreas Filippi; Michael Payer; Bernd d'Hoedt; Matthias Kreisler
Journal:  Clin Oral Investig       Date:  2012-04-27       Impact factor: 3.573

2.  The association of human primary bone cells with biphasic calcium phosphate (βTCP/HA 70:30) granules increases bone repair.

Authors:  Ronaldo de Oliveira Lomelino; Igor Iuco Castro-Silva; Adriana Brandão Ribeiro Linhares; Gutemberg Gomes Alves; Sílvia Raquel de Albuquerque Santos; Vinicius Schott Gameiro; Alexandre Malta Rossi; José Mauro Granjeiro
Journal:  J Mater Sci Mater Med       Date:  2011-12-27       Impact factor: 3.896

3.  Maxillary sinus floor augmentation on humans: Packing simulations and 8 months histomorphometric comparative study of anorganic bone matrix and β-tricalcium phosphate particles as grafting materials.

Authors:  A Martinez; J Franco; E Saiz; F Guitian
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2010-06-15       Impact factor: 7.328

4.  Benefits of biphasic calcium phosphate hybrid scaffold-driven osteogenic differentiation of mesenchymal stem cells through upregulated leptin receptor expression.

Authors:  Chi-Chien Niu; Song-Shu Lin; Wen-Jer Chen; Shih-Jung Liu; Lih-Huei Chen; Chuen-Yung Yang; Chao-Jan Wang; Li-Jen Yuan; Po-Han Chen; Hsiao-Yang Cheng
Journal:  J Orthop Surg Res       Date:  2015-07-16       Impact factor: 2.359

5.  The use of hydroxyapatite bone substitute grafting for alveolar ridge preservation, sinus augmentation, and periodontal bone defect: A systematic review.

Authors:  Anne Handrini Dewi; Ika Dewi Ana
Journal:  Heliyon       Date:  2018-11-02

6.  Synthetic bone substitute engineered with amniotic epithelial cells enhances bone regeneration after maxillary sinus augmentation.

Authors:  Barbara Barboni; Carlo Mangano; Luca Valbonetti; Giuseppe Marruchella; Paolo Berardinelli; Alessandra Martelli; Aurelio Muttini; Annunziata Mauro; Rossella Bedini; Maura Turriani; Raffaella Pecci; Delia Nardinocchi; Vincenzo Luca Zizzari; Stefano Tetè; Adriano Piattelli; Mauro Mattioli
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.